A5027779844- Diabetes Treatment and Management
- Health Systems, Economic Evaluations, Quality of Life
- EEG and Brain-Computer Interfaces
- Biomedical and Chemical Research
- Metabolism, Diabetes, and Cancer
- Lipoproteins and Cardiovascular Health
- Intracranial Aneurysms: Treatment and Complications
- Cardiovascular Function and Risk Factors
- Epilepsy research and treatment
- Cardiac, Anesthesia and Surgical Outcomes
- Gastric Cancer Management and Outcomes
- Heart Failure Treatment and Management
- Anesthesia and Neurotoxicity Research
- Medication Adherence and Compliance
- Poisoning and overdose treatments
- Electroconvulsive Therapy Studies
- Medicinal plant effects and applications
- Orthopedic Surgery and Rehabilitation
- Blood disorders and treatments
- Diabetes Management and Education
- Peripheral Artery Disease Management
- Hip and Femur Fractures
- Sinusitis and nasal conditions
- Autoimmune Neurological Disorders and Treatments
- Diabetes Management and Research
Associazione Medici Diabetologi
2020-2021
University of Naples Federico II
1967
The PIONEER REAL Italy study examined the clinical outcomes associated with oral semaglutide in real-world settings. This was a multicenter, prospective, non-interventional, single-arm adults type 2 diabetes (T2D) who were treatment-naive to injectable glucose-lowering medications. Participants initiated at doses of 3, 7, or 14 mg, and followed for 34-44 weeks. primary endpoint change glycated hemoglobin (HbA1c) from baseline end (EoS). Secondary endpoints body weight (BW), percentage...
Abstract Background Greater efforts are needed to overcome the worldwide reported low achievement of LDL-c targets. This survey aimed dissect whether and how physician-based evaluation patients with diabetes is associated Methods cross-sectional self-reported interviewed physicians working in 67 outpatient services Italy, collecting records on 2844 diabetes. Each physician a median 47 (IQR 42–49) and, for each them, specified its perceived cardiovascular risk, targets, suggested refinement...
This study aimed to address therapeutic inertia in the management of type 2 diabetes (T2D) by investigating potential early treatment with oral semaglutide. A cross-sectional survey was conducted between October 2021 and April 2022 among specialists treating individuals T2D. scientific committee designed a data collection form covering demographics, cardiovascular risk, glucose control metrics, ongoing therapies, physician judgments on appropriateness. Participants completed anonymous...
Abstract Background SCODIAC study revealed an increasing use of SGLT2 inhibitors in 123 patients affected with Heart Failure (HF) and Type 2 Diabetes Mellitus (T2DM), referred to Cardiologists Diabetologists the pertaining healthcare districts. Follow Up, second phase program, has been carried out determine diagnostic therapeutic pathways a larger group HF diabetic verify whether innovative antidiabetic therapies could modify echocardiographic parameters influence cardiological therapy....